DE69111801D1 - Vakzin gegen hepatitis b. - Google Patents

Vakzin gegen hepatitis b.

Info

Publication number
DE69111801D1
DE69111801D1 DE69111801T DE69111801T DE69111801D1 DE 69111801 D1 DE69111801 D1 DE 69111801D1 DE 69111801 T DE69111801 T DE 69111801T DE 69111801 T DE69111801 T DE 69111801T DE 69111801 D1 DE69111801 D1 DE 69111801D1
Authority
DE
Germany
Prior art keywords
vhbsag
vaccine against
against hepatitis
fragment
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69111801T
Other languages
English (en)
Other versions
DE69111801T2 (de
Inventor
Carman Wiliam Frederick
Thomas Howard Christopher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial College of Science Technology and Medicine
Original Assignee
Imperial College of Science Technology and Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College of Science Technology and Medicine filed Critical Imperial College of Science Technology and Medicine
Application granted granted Critical
Publication of DE69111801D1 publication Critical patent/DE69111801D1/de
Publication of DE69111801T2 publication Critical patent/DE69111801T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69111801T 1990-03-29 1991-03-25 Vakzin gegen hepatitis b. Expired - Fee Related DE69111801T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909007024A GB9007024D0 (en) 1990-03-29 1990-03-29 Novel vaccine
PCT/GB1991/000444 WO1991014703A1 (en) 1990-03-29 1991-03-25 Hepatitis b vaccine

Publications (2)

Publication Number Publication Date
DE69111801D1 true DE69111801D1 (de) 1995-09-07
DE69111801T2 DE69111801T2 (de) 1995-12-14

Family

ID=10673467

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69111801T Expired - Fee Related DE69111801T2 (de) 1990-03-29 1991-03-25 Vakzin gegen hepatitis b.

Country Status (16)

Country Link
US (1) US6099840A (de)
EP (1) EP0522030B1 (de)
JP (2) JP2876091B2 (de)
KR (1) KR100208129B1 (de)
AT (1) ATE125821T1 (de)
CA (1) CA2078694C (de)
DE (1) DE69111801T2 (de)
DK (1) DK0522030T3 (de)
ES (1) ES2075440T3 (de)
GB (1) GB9007024D0 (de)
GR (1) GR3017804T3 (de)
IE (1) IE67877B1 (de)
NZ (1) NZ237611A (de)
PT (1) PT97159B (de)
WO (1) WO1991014703A1 (de)
ZA (1) ZA912305B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565354A (en) * 1986-09-05 1996-10-15 Sandoz Ltd. Production of human monoclonal antibodies specific for hepatitis B surface antigen
CA2067003A1 (en) * 1991-04-29 1992-10-30 Peter J. Kniskern Hbsag escape mutant vaccine
EP0533263A3 (en) * 1991-09-20 1994-06-08 Merck & Co Inc A multivalent hepatitis b virus vaccine
WO1993012815A1 (en) * 1991-12-27 1993-07-08 Gensci Limited Method for obtaining recombinant surface antigen of hepatitis b, antigen and vaccine based on it
JPH07505412A (ja) * 1992-04-14 1995-06-15 ブリティッシュ　バイオテック　ファーマシューティカルズリミテッド Ｃｔｌ応答の誘導
JP3626996B2 (ja) 1992-05-23 2005-03-09 グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム Ｂ型肝炎表面抗原および他の抗原からなる複合ワクチン
US5750106A (en) * 1993-01-28 1998-05-12 Novartis Ag Human monoclonal antibodies to cytomegalovirus
CA2158866A1 (en) * 1993-03-24 1994-09-29 Jennifer Anne Waters Hepatitis b escape mutant specific binding molecules
US6030616A (en) * 1993-03-24 2000-02-29 Imperial College Of Science, Technology & Medicine Hepatitis B escape mutant specific binding molecules
US5595739A (en) * 1993-05-07 1997-01-21 Abbott Laboratories Hepatitis B virus mutants, reagents and methods for detection
GB9401987D0 (en) * 1994-02-02 1994-03-30 Imperial College Modified nucleic acid
GB9623233D0 (en) 1996-11-07 1997-01-08 Smithkline Beecham Biolog Vaccine composition
EP0919568A1 (de) 1997-12-01 1999-06-02 Sorin Diagnostics S.r.l. Fluchtmutanten des Oberflächenantigens des Hepatitis B Virus
MXPA00012724A (es) * 1998-06-19 2003-02-10 Government Of The Republic Of Una cepa viral de hepatitis b inducida por vacuna y usos de la misma.
WO2000023105A2 (en) 1998-10-16 2000-04-27 Smithkline Beecham Biologicals S.A. Adjuvant systems and vaccines
AUPP967999A0 (en) 1999-04-09 1999-05-06 North Western Health Care Network Viral variants
UA79735C2 (uk) 2000-08-10 2007-07-25 Глаксосмітклайн Байолоджікалз С.А. Очищення антигенів вірусу гепатиту b (hbv) для використання у вакцинах
FR2815634B1 (fr) * 2000-10-20 2003-10-31 Biomerieux Sa Anticorps monoclonaux diriges contre des virus de l'hepatite b
JP4430677B2 (ja) 2004-09-22 2010-03-10 株式会社先端生命科学研究所 Ｂ型肝炎ウイルスｓ抗原の検出法
BRPI0610297A2 (pt) * 2005-04-18 2010-06-08 Novartis Vaccines & Diagnostic expressão de antìgeno de superfìcie de vìrus da hepatite b para a preparação de vacina
WO2007106536A2 (en) 2006-03-14 2007-09-20 Oregon Health & Science University Methods for producing an immune response to tuberculosis
ATE511398T1 (de) 2006-09-07 2011-06-15 Glaxosmithkline Biolog Sa Inaktiviertes poliovirus mischimpfstoff
EP2918598B1 (de) 2007-02-28 2019-01-30 The Govt. Of U.S.A. As Represented By The Secretary Of The Department Of Health And Human Services Brachyurie-Polypeptide und Verwendungsverfahren
MX2009011837A (es) 2007-05-02 2010-04-22 Glaxosmithkline Biolog Sa Vacuna.
US9415006B2 (en) 2008-05-23 2016-08-16 The Regents Of The University Of Michigan Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same
US8664183B2 (en) 2009-02-27 2014-03-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services SPANX-B polypeptides and their use
GB201105981D0 (en) 2011-04-08 2011-05-18 Glaxosmithkline Biolog Sa Novel process
CA2878155C (en) * 2012-07-10 2019-01-08 Green Cross Corporation An antibody composition for prevention or treatment of mutant hepatitis b virus infection
US20150224181A1 (en) 2012-09-14 2015-08-13 The United States Of America As Represented By The Secretary Department Of Health And Human Se Brachyury protein, non-poxvirus non-yeast vectors encoding brachyury protein, and their use
RU2603729C2 (ru) * 2015-04-24 2016-11-27 Закрытое акционерное общество научно-производственная компания "Комбиотех" Рекомбинантная вакцина для профилактики вирусного гепатита в (варианты)
RU2586513C1 (ru) * 2015-04-24 2016-06-10 Закрытое акционерное общество научно-производственная компания "Комбиотех" РЕКОМБИНАНТНЫЙ ШТАММ ДРОЖЖЕЙ Hansenula polymorpha - ПРОДУЦЕНТ МУТАНТНОГО ПОВЕРХНОСТНОГО АНТИГЕНА ВИРУСА ГЕПАТИТА В (ВАРИАНТЫ)
CN108289940B (zh) 2015-08-03 2023-01-13 美国卫生和人力服务部 Brachyury缺失突变体、编码brachyury缺失突变体的非酵母载体及其用途

Also Published As

Publication number Publication date
ZA912305B (en) 1992-01-29
KR100208129B1 (ko) 1999-07-15
WO1991014703A1 (en) 1991-10-03
AU642729B2 (en) 1993-10-28
DK0522030T3 (da) 1995-12-27
JP2876091B2 (ja) 1999-03-31
ES2075440T3 (es) 1995-10-01
US6099840A (en) 2000-08-08
AU7561391A (en) 1991-10-21
DE69111801T2 (de) 1995-12-14
CA2078694C (en) 1998-10-27
IE67877B1 (en) 1996-05-01
EP0522030A1 (de) 1993-01-13
NZ237611A (en) 1994-09-27
GR3017804T3 (en) 1996-01-31
IE911022A1 (en) 1991-10-09
ATE125821T1 (de) 1995-08-15
JPH11178591A (ja) 1999-07-06
PT97159A (pt) 1991-12-31
EP0522030B1 (de) 1995-08-02
PT97159B (pt) 1998-07-31
GB9007024D0 (en) 1990-05-30
JPH05505805A (ja) 1993-08-26
JP3049018B2 (ja) 2000-06-05
CA2078694A1 (en) 1991-09-30

Similar Documents

Publication Publication Date Title
DE69111801T2 (de) Vakzin gegen hepatitis b.
MX9603182A (es) Vacuna de hepatitis b.
DK0527815T3 (da) Hepatitis C-virus-epitop
BR9306820A (pt) Conjugado de um antígeno fracamente imunogênico e um veículo peptideo sintetico vacina processos para melhorar a imunogenicidade de uma molecula de antigeno fracamente imunogenico e para imunizar um hospedeiro mamífero
CA2103887A1 (en) Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
PT101052A (pt) Proteinas hibridas uteis na preparacao de vacinas
BR9106220A (pt) Antigenos sinteticos para a deterccao de anticorpos para o virus da hepatite c.
KR910019641A (ko) 사람 유두종 바이러스(hpv) 18의 단백질상의 혈청 반응성 에피토프
NZ535908A (en) HIV regulatory and auxilliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
KR920002629A (ko) B형 간염 코어 항원의 아미노산 잔기 서열
DE60115938D1 (de) Monoklonale antikörper gegen hepatitis b virus
ATE189683T1 (de) Hcv peptidantigene und verfahren zur bestimmung von hcv
DE69011122D1 (de) Rubella-e1 und c peptide.
WO2002051865A3 (fr) Antigenes proteiques inducteurs d'anticorps neutralisant le virus vih
BRPI0204599B8 (pt) kit para a detecção simultânea de anticorpo para hcv e antígeno de hcv
AU1146692A (en) Recombinant proteins with the immunoreactivity of hepatitis b virus e antigen (hbeag), a process for the preparation thereof and the use thereof in immunoassays and vaccines

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: GROSSE, BOCKHORNI, SCHUMACHER, 81476 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: GROSSE, SCHUMACHER, KNAUER, VON HIRSCHHAUSEN, 8033

8339 Ceased/non-payment of the annual fee